Continuous effectiveness and safety after a hospital‐wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Continuous effectiveness and safety after a hospital‐wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patients

Published:2022-12 Issue:6 Volume:10 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacology Res & Perspec

Author:

Brouwer Rianne¹,ten Klooster Peter M.²,Masselink Joost B.³,Vonkeman Harald E.¹²^ORCID

Affiliation:

1. Department of Rheumatology and Clinical Immunology Medisch Spectrum Twente Enschede The Netherlands

2. Department of Psychology, Health and Technology University of Twente Enschede The Netherlands

3. Department of Clinical Pharmacy Medisch Spectrum Twente Enschede The Netherlands

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.1025

Reference35 articles.

1. Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care

2. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

3. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

4. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

5. Costs of rheumatoid arthritis during the period 1990-2010: a register-based cost-of-illness study in Sweden

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacillus coagulans BACO-17 ameliorates in vitro and in vivo progression of Rheumatoid arthritis;International Immunopharmacology;2024-11

2. Clinical outcomes of switching to adalimumab biosimilar (MSB11022) in patients with rheumatoid arthritis: RESTART Spanish Registry;Current Medical Research and Opinion;2024-07-04

3. Patient Experience with the SensoReady® Autoinjector Pen versus a Comparator Device: Results from a Canadian Patient Survey in Rheumatoid Arthritis and Crohn´s Disease;Patient Preference and Adherence;2024-06

4. A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis;Expert Opinion on Drug Safety;2024-05-23

5. Adalimumab;Reactions Weekly;2023-01-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3